Register Cart 0

Generic placeholder image

CNS & Neurological Disorders - Drug Targets

Editor-in-Chief

ISSN (Print): 1871-5273
ISSN (Online): 1996-3181

Back Subscribe

Editorial

Editorial: Combining Forces to Improve Alzheimer’s Disease Drug Discovery: The Symptomatic Battle

Author(s): Julie Deguil, Alexandra Auffret, Esther Schenker, Fabienne Aujard, Yves Lamberty, David Bartrès-Faz, Olivier Blin, Joëlle Micallef, Jill C. Richardson and Régis Bordet

Volume 15, Issue 7, 2016

Page: [754 - 755] Pages: 2

DOI: 10.2174/187152731507160808200737

« Previous Next »

Rights & Permissions Print Cite

Article Metrics

95

Journal Information

For Authors

For Editors

For Reviewers

Explore Articles

Open Access

Open Access Articles

For Visitors

Related Articles

Psychedelics as Medicines for Substance Abuse Rehabilitation: Evaluating Treatments with LSD, Peyote, Ibogaine and Ayahuasca
Current Drug Abuse Reviews

Common Molecular Targets for Bioactive Food Components and Drugs
Current Pediatric Reviews

Two -Year Efficacy and Safety of Botulinum a Toxin Intravesical Injections in Patients Affected by Refractory Painful Bladder Syndrome
Current Drug Delivery

Incorporation of Targeted Agents in the Management of Patients with Advanced Gastric Cancer
Current Medicinal Chemistry

Can't Always Get What you Want? Try an Indirect Route you Just Might Get What you Need: A Study on Access to Genetic Data by Canadian Life Insurers
Current Pharmacogenomics and Personalized Medicine

RNA Binding Protein/RNA Element Interactions and the Control of Translation
Current Protein & Peptide Science

A Longitudinal FDG-PET Study of Transgenic Mice Overexpressing GSK- 3β in the Brain
Current Alzheimer Research

Oligomeric Amyloid β -Protein as a Therapeutic Target in Alzheimers Disease: Its Significance Based on its Distinct Localization and the Occurrence of a Familial Variant Form
Current Alzheimer Research

Natural Products as Potential Anti-Alzheimer Agents
Current Medicinal Chemistry

Recent Patents on the Treatment of Type 1 Diabetes
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued)

Novel Strategies in Drug Discovery of the Calcium-Sensing Receptor Based on Biased Signaling
Current Drug Targets

Serotonin 5-HT2A and 5-HT2C Receptors as Potential Targets for Modulation of Psychostimulant Use and Dependence
Current Topics in Medicinal Chemistry

The NMDA Receptor/Ion Channel Complex: A Drug Target for Modulating Synaptic Plasticity and Excitotoxicity
Current Pharmaceutical Design

“A Novel Approach to Case Based Discussions”
Applied Clinical Research, Clinical Trials and Regulatory Affairs

How to Review the Medication History to Find the Next Best Drug: The “Pretreatment-Next Treatment Algorithm and Checklist”
Current Psychopharmacology

Investigations into the Inhibition of Luminol Chemiluminescence by some Novel Metal Complexes
Current Analytical Chemistry

Neurobiology of Sleep Disturbances in Neurodegenerative Disorders
Current Pharmaceutical Design

Characterization of Single Nucleotide Polymorphisms of Cytochrome P450 in an Australian Deceased Sample
Current Drug Metabolism

Adenosine Myocardial Perfusion Imaging
Current Medical Imaging

The Multiple Layers of Signaling Selectivity at Protease-Activated Receptors
Current Pharmaceutical Design

© 2024 Bentham Science Publishers | Privacy Policy